Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 62
Filter
Add more filters

Publication year range
1.
Int J Mol Sci ; 20(10)2019 May 23.
Article in English | MEDLINE | ID: mdl-31126033

ABSTRACT

Nowadays, the oral use of probiotics is widespread. However, the safety profile with the use of live probiotics is still a matter of debate. Main risks include: Cases of systemic infections due to translocation, particularly in vulnerable patients and pediatric populations; acquisition of antibiotic resistance genes; or interference with gut colonization in neonates. To avoid these risks, there is an increasing interest in non-viable microorganisms or microbial cell extracts to be used as probiotics, mainly heat-killed (including tyndallized) probiotic bacteria (lactic acid bacteria and bifidobacteria). Heat-treated probiotic cells, cell-free supernatants, and purified key components are able to confer beneficial effects, mainly immunomodulatory effects, protection against enteropathogens, and maintenance of intestinal barrier integrity. At the clinical level, products containing tyndallized probiotic strains have had a role in gastrointestinal diseases, including bloating and infantile coli-in combination with mucosal protectors-and diarrhea. Heat-inactivated probiotics could also have a role in the management of dermatological or respiratory allergic diseases. The reviewed data indicate that heat-killed bacteria or their fractions or purified components have key probiotic effects, with advantages versus live probiotics (mainly their safety profile), positioning them as interesting strategies for the management of common prevalent conditions in a wide variety of patients´ characteristics.


Subject(s)
Bifidobacterium/cytology , Lactobacillus/cytology , Probiotics/therapeutic use , Animals , Bacterial Infections/microbiology , Bacterial Infections/therapy , Gastrointestinal Diseases/microbiology , Gastrointestinal Diseases/therapy , Hot Temperature , Humans , Immunomodulation , Microbial Viability , Probiotics/adverse effects
2.
J Clin Gastroenterol ; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017: S57-S61, 2018.
Article in English | MEDLINE | ID: mdl-29864069

ABSTRACT

GOALS: The aim of this research was to evaluate whether micronized cells (MCs) from selected biotherapeutic bacteria have the ability to effectively modulate the polarization of monocyte/macrophage subpopulations to advantageously provide a first line of defense against infections. BACKGROUND: Inflammation is a reaction of the host to viral and bacterial infections with the physiological purpose of restoring tissue homeostasis. However, uncontrolled or unresolved inflammation can lead to tissue damage, giving rise to a plethora of chronic inflammatory diseases. The monocytes/macrophages play a key role in the initiation and resolution of inflammation through different activation programs. STUDY: MCs were obtained from Bifidobacterium lactis BS01 strain using a Bioimmunizer extraction protocol. Monocytes were stimulated with the probiotic strain and/or MCs (10 mg/mL) for 24 hours and 5 days. Monocyte/macrophage differentiation was evaluated by cytometry analysis of surface markers and the activity of the 2 subpopulations on oxidative stress was assessed in an in vitro oxidative stress model with a spectrophotometric test. RESULTS: The MCs have been shown to modulate considerably the 2 subpopulations of human monocytes/macrophages, both the "patrolling subpopulation" and the "inflammatory subpopulation," thus highlighting a strong immunostimulatory effect. In addition, MCs are able to mitigate significantly the oxidative stress induced by homocysteine in an in vitro model. CONCLUSIONS: Our findings suggest that MCs derived from the biotherapeutic strain BS01 could represent a possible therapy aimed to effectively prevent and/or cure viral, bacterial, fungal, or protozoal diseases, as well as prevent and/or treat inflammatory processes triggered by external pathogenic agents.


Subject(s)
Bifidobacterium/cytology , Cell Polarity/physiology , Macrophages/microbiology , Monocytes/microbiology , Probiotics/pharmacology , Cell Differentiation/physiology , Humans , Leukocytes, Mononuclear , Macrophages/physiology , Monocytes/physiology , Oxidative Stress
3.
Anal Bioanal Chem ; 410(3): 943-952, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28852794

ABSTRACT

The aim of the study was to neutralize zearalenone by lactic acid bacteria (LAB) such as Lactococcus lactis and Bifidobacterium sp. and investigate the mechanism of zearalenone (ZEA) binding. Neutralization of ZEA by LAB was confirmed by identification of binding kinetics and spectroscopic studies such as Fourier transform infrared spectroscopy (FT-IR) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). The obtained results showed that the kinetic process of zearalenone binding to L. lactis is not homogeneous but is expressed with an initial rapid stage with about 90% of ZEA biosorption and with a much slower second step. In case of Bifidobacterium sp., the neutralization process is homogeneous; the main stage can be described with about 88% of ZEA biosorption. MALDI-TOF-MS measurements and FTIR analysis confirmed the uptake of zearalenone molecules by bacterial species. Moreover, the assessment of dead and live lactic acid bacteria cells after zearalenone treatment was performed using fluorescence microscopy. Graphical abstract Microbiology neutralization of zearalenone using Lactococcus lactis and Bifidobacterium sp. was confirmed by identification of binding kinetics and spectroscopic studies such as FT-IR spectroscopy and MALDI-TOF-MS spectrometry. The mechanism of ZEA binding was also investigated.


Subject(s)
Bifidobacterium/metabolism , Lactococcus lactis/metabolism , Zearalenone/metabolism , Adsorption , Bifidobacterium/cytology , Lactococcus lactis/cytology , Microbial Viability , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Spectroscopy, Fourier Transform Infrared
4.
BMC Genomics ; 18(1): 41, 2017 01 06.
Article in English | MEDLINE | ID: mdl-28061804

ABSTRACT

BACKGROUND: Bifidobacteria are among the first anaerobic bacteria colonizing the gut. Bifidobacteria require iron for growth and their iron-sequestration mechanisms are important for their fitness and possibly inhibit enteropathogens. Here we used combined genomic and proteomic analyses to characterize adaptations to low iron conditions of B. kashiwanohense PV20-2 and B. pseudolongum PV8-2, 2 strains isolated from the feces of iron-deficient African infants and selected for their high iron-sequestering ability. RESULTS: Analyses of the genome contents revealed evolutionary adaptation to low iron conditions. A ferric and a ferrous iron operon encoding binding proteins and transporters were found in both strains. Remarkably, the ferric iron operon of B. pseudolongum PV8-2 is not found in other B. pseudolongum strains and likely acquired via horizontal gene transfer. The genome B. kashiwanohense PV20-2 harbors a unique region encoding genes putatively involved in siderophore production. Additionally, the secretomes of the two strains grown under low-iron conditions were analyzed using a combined genomic-proteomic approach. A ferric iron transporter was found in the secretome of B. pseudolongum PV8-2, while ferrous binding proteins were detected in the secretome of B. kashiwanohense PV20-2, suggesting different strategies to take up iron in the strains. In addition, proteins such as elongation factors, a glyceraldehyde-3-phosphate dehydrogenase, and the stress proteins GroEL and DnaK were identified in both secretomes. These proteins have been previously associated with adhesion of lactobacilli to epithelial cells. CONCLUSION: Analyses of the genome and secretome of B. kashiwanohense PV20-2 and B. pseudolongum PV8-2 revealed different adaptations to low iron conditions and identified extracellular proteins for iron transport. The identified extracellular proteins might be involved in competition for iron in the gastrointestinal tract.


Subject(s)
Adaptation, Physiological/drug effects , Bifidobacterium/cytology , Bifidobacterium/metabolism , Extracellular Space/drug effects , Extracellular Space/metabolism , Iron/pharmacology , Proteomics , Bifidobacterium/drug effects , Bifidobacterium/physiology , Dose-Response Relationship, Drug , Evolution, Molecular , Species Specificity
5.
Food Microbiol ; 49: 197-202, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25846931

ABSTRACT

The aim of the current study was to investigate the effect of varying sodium chloride concentrations (0-5%) on viability and membrane integrity of three probiotic bacteria, Lactobacillus acidophilus, Lactobacillus casei and Bifidobacterium longum, using conventional technique and flow cytometry. Double staining of cells by carboxyfluorescein diacetate (cFDA) and propidium iodide (PI) enabled to evaluate the effect of NaCl on cell esterase activity and membrane integrity. Observations from conventional culture technique were compared with findings from flow cytometric analysis on the metabolic activities of the cells and a correlation was observed between culturability and dye extrusion ability of L. casei and B. longum. However, a certain population of L. acidophilus was viable as per the plate count method but its efflux activity was compromised. Esterase activity of most bacteria reduced significantly (P < 0.05) during one week storage at NaCl concentrations greater than 3.5%. The study revealed that L. casei was least affected by higher NaCl concentrations among the three probiotic bacteria, as opposed to B. longum where the cF extrusion performance was greatly reduced during 1 wk storage. The metabolic activity and salt resistance of L. casei was found to be highest among the bacteria studied.


Subject(s)
Bifidobacterium/growth & development , Lacticaseibacillus casei/growth & development , Lactobacillus acidophilus/growth & development , Sodium Chloride/metabolism , Bifidobacterium/cytology , Bifidobacterium/metabolism , Flow Cytometry/methods , Lactobacillus acidophilus/cytology , Lactobacillus acidophilus/metabolism , Lacticaseibacillus casei/cytology , Lacticaseibacillus casei/metabolism , Microbial Viability
6.
J Microencapsul ; 32(4): 372-80, 2015.
Article in English | MEDLINE | ID: mdl-26004368

ABSTRACT

In this study the application of thermo-sensitive sol-gel polymers in microencapsulation formulation of probiotic bacteria, Bifidobacterium animalis spp lactis, for powdered infant formula (PIF), which is reconstituted at 70 °C, has been assessed. A double-layered microcapsule containing hydroxypropyl methyl cellulose (HPMC) as an inner layer and an outer layer, as the smart coating layer, based on a combination of hydroxypropyl cellulose (HPC) and poloxamer was designed. Generally, this specific microencapsulation provided superior protection against the reconstitution temperature. A high molecular weight of HPC and a greater thickness of the smart coating layer resulted in a delayed release of the bacteria from the microcapsules especially in the PIF composition. However, this was compensated by a high stability of the bacteria at 70 °C. Both the surface texture and particle size distribution of microcapsules have been respectively characterised by scanning electron microscopy and particle size analysis.


Subject(s)
Bifidobacterium/cytology , Capsules/chemistry , Cellulose/analogs & derivatives , Hypromellose Derivatives/chemistry , Infant Formula/microbiology , Poloxamer/chemistry , Probiotics/administration & dosage , Cellulose/chemistry , Drug Compounding , Humans , Infant , Phase Transition , Temperature
7.
J Microencapsul ; 32(4): 329-35, 2015.
Article in English | MEDLINE | ID: mdl-25775038

ABSTRACT

This study evaluated the effect of honey addition on the viability of free and emulsion encapsulated cells of two strains of Bifidobacterium that underwent simulation of human upper gastrointestinal transit. In the control condition, without honey, free cells were drastically reduced after exposure to gastrointestinal conditions. The reduction was more pronounced with Bifidobacterium J7 of human origin. On the other hand, when cells were encapsulated, the viability reduction was higher for strain Bifidobacterium Bb12. The microencapsulation improved the viability maintenance of both Bifidobacterium strains, in recommended amounts for probiotic activity, after exposure to simulated gastrointestinal conditions. Moreover, suspending free cells of both Bifidobacterium strains in honey solutions resulted in a protective effect, equivalent to the plain microencapsulation with sodium alginate 3%. It is concluded that microencapsulation and the addition of honey improved the ability of Bifidobacterium to tolerate gastrointestinal conditions in vitro.


Subject(s)
Bifidobacterium/cytology , Drug Compounding/methods , Gastrointestinal Tract/microbiology , Honey , Microbial Viability , Probiotics , Bifidobacterium/metabolism , Cells, Immobilized/cytology , Cells, Immobilized/metabolism , Emulsions/chemistry , Gastrointestinal Transit , Honey/analysis , Humans , Probiotics/analysis
8.
Caries Res ; 48(5): 451-60, 2014.
Article in English | MEDLINE | ID: mdl-24852305

ABSTRACT

Microbiological studies of occlusal dental biofilms have hitherto been hampered by inaccessibility to the sampling site and demolition of the original biofilm architecture. This study shows for the first time the spatial distribution of bacterial taxa in vivo at various stages of occlusal caries, applying a molecular methodology involving preparation of embedded hard dental tissue slices for fluorescence in situ hybridization (FISH) and confocal microscopy. Eleven freshly extracted teeth were classified according to their occlusal caries status. The teeth were fixed, embedded, sectioned and decalcified before FISH was performed using oligonucleotide probes for selected abundant species/genera associated with occlusal caries including Streptococcus, Actinomyces, Veillonella, Fusobacterium, Lactobacillus and Bifidobacterium. The sites showed distinct differences in the bacterial composition between different ecological niches in occlusal caries. Biofilm observed along the entrance of fissures showed an inner layer of microorganisms organized in palisades often identified as Actinomyces, covered by a more loosely structured bacterial layer consisting of diverse genera, similar to supragingival biofilm. Biofilm within the fissure proper seemed less metabolically active, as judged by low fluorescence signal intensity and presence of material of non-bacterial origin. Bacterial invasion (often Lactobacillus and Bifidobacterium spp.) into the dentinal tubules was seen only at advanced stages of caries with manifest cavity formation. It is concluded that the molecular methodology represents a valuable supplement to previous methods for the study of microbial ecology in caries by allowing analysis of the structural composition of the undisturbed biofilm in caries lesions in vivo.


Subject(s)
Bacteria/cytology , Biofilms , Dental Caries/microbiology , Actinomyces/cytology , Bacteria/classification , Bifidobacterium/cytology , Dental Enamel/microbiology , Dental Fissures/microbiology , Dentin/microbiology , Dentin/ultrastructure , Fusobacterium/cytology , Humans , In Situ Hybridization, Fluorescence , Lactobacillus/cytology , Microbial Consortia , Microscopy, Confocal , Molecular Biology , Plastic Embedding , Streptococcus/classification , Streptococcus/cytology , Streptococcus mitis/cytology , Streptococcus mutans/cytology , Veillonella/cytology
9.
J Biol Chem ; 287(1): 693-700, 2012 Jan 02.
Article in English | MEDLINE | ID: mdl-22090027

ABSTRACT

Bifidobacteria inhabit the lower intestine of mammals including humans where the mucin gel layer forms a space for commensal bacteria. We previously identified that infant-associated bifidobacteria possess an extracellular membrane-bound endo-α-N-acetylgalactosaminidase (EngBF) that may be involved in degradation and assimilation of mucin-type oligosaccharides. However, EngBF is highly specific for core-1-type O-glycan (Galß1-3GalNAcα1-Ser/Thr), also called T antigen, which is mainly attached onto gastroduodenal mucins. By contrast, core-3-type O-glycans (GlcNAcß1-3GalNAcα1-Ser/Thr) are predominantly found on the mucins in the intestines. Here, we identified a novel α-N-acetylgalactosaminidase (NagBb) from Bifidobacterium bifidum JCM 1254 that hydrolyzes the Tn antigen (GalNAcα1-Ser/Thr). Sialyl and galactosyl core-3 (Galß1-3/4GlcNAcß1-3(Neu5Acα2-6)GalNAcα1-Ser/Thr), a major tetrasaccharide structure on MUC2 mucin primarily secreted from goblet cells in human sigmoid colon, can be serially hydrolyzed into Tn antigen by previously identified bifidobacterial extracellular glycosidases such as α-sialidase (SiaBb2), lacto-N-biosidase (LnbB), ß-galactosidase (BbgIII), and ß-N-acetylhexosaminidases (BbhI and BbhII). Because NagBb is an intracellular enzyme without an N-terminal secretion signal sequence, it is likely involved in intracellular degradation and assimilation of Tn antigen-containing polypeptides, which might be incorporated through unknown transporters. Thus, bifidobacteria possess two distinct pathways for assimilation of O-glycans on gastroduodenal and intestinal mucins. NagBb homologs are conserved in infant-associated bifidobacteria, suggesting a significant role for their adaptation within the infant gut, and they were found to form a new glycoside hydrolase family 129.


Subject(s)
Bifidobacterium/enzymology , Mucins/metabolism , Proteolysis , alpha-N-Acetylgalactosaminidase/metabolism , Bifidobacterium/cytology , Bifidobacterium/genetics , Biocatalysis , Carbohydrate Sequence , Cloning, Molecular , Humans , Infant , Intracellular Space/enzymology , Molecular Sequence Data , Phylogeny , alpha-N-Acetylgalactosaminidase/genetics
10.
Anaerobe ; 23: 23-6, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23916721

ABSTRACT

This paper reports on the effects of lactulose (0-10 g/l) on Bifidobacterium animalis subsp. lactis, along with the influence of pH (4.5-8.5) and temperature (15-45 °C); the three factors were combined through a simplex centroid. The experiments were performed in a laboratory medium and the data of cells counts were modeled through the Weibull equation for the evaluation of the first reduction time, the shape parameter and the death time. These fitting parameters were used as input values to build a desirability profile and a second-order model through the DoE approach (Design of Experiments). The medium containing glucose was used as control. The prebiotic enhanced the viability of the microbial target, by prolonging the first reduction time and inducing a shoulder phase in the death kinetic; moreover, in some combinations the statistical analysis highlighted a kind of interaction with the pH.


Subject(s)
Bifidobacterium/drug effects , Bifidobacterium/radiation effects , Lactulose/metabolism , Microbial Viability/drug effects , Microbial Viability/radiation effects , Bifidobacterium/cytology , Humans , Hydrogen-Ion Concentration , Models, Theoretical , Temperature
11.
J Microencapsul ; 30(6): 511-8, 2013.
Article in English | MEDLINE | ID: mdl-23405847

ABSTRACT

Six kinds of Bifidobacterium bifidum microcapsules were prepared by extrusion methods, emulsion methods and coacervation methods. Effects of preparation methods on the survival of encapsulated B. bifidum were examined. Results showed that microcapsules prepared by emulsion method with alginate and chitosan exhibited the best protection for B. bifidum. The diameter was 10-20 µm, encapsulation efficiency was 90.36% and the live cell amount was 3.01 × 109 cfu/g after freeze-drying. Encapsulated cells exhibited significantly higher resistance to artificial gastrointestinal juice and the cell numbers were above 109 cfu/g after exposure to simulated gastric (pH 1.2) and bile salt (1%, w/v). Cell numbers of microencapsulated B. bifidum was 8.61 × 108 cfu/g after storage at 37°C, relative humidity 60%-65% for 3 months. Results indicated microcapsules prepared with alginate and chitosan by emulsion method could successfully protect B. bifidum against adverse conditions and it might be useful in the delivery of probiotic cultures as a functional food.


Subject(s)
Bifidobacterium/cytology , Probiotics/administration & dosage , Alginates/chemistry , Capsules/chemistry , Chitosan/chemistry , Drug Compounding/methods , Emulsions/chemistry , Freeze Drying , Glucuronic Acid/chemistry , Hexuronic Acids/chemistry , Microbial Viability
12.
Pol J Microbiol ; 61(4): 305-10, 2012.
Article in English | MEDLINE | ID: mdl-23484414

ABSTRACT

In this study sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) profiles were analysed and differences were confirmed by a unweighted pair group method with arithmetic average (UPGMA) analysis between bifidobacterial species, such as B. infanis ATCC1567, B. bifidum Bb-12, B. longum KN29, B. catenulatum KD14, and B. animalis BI30. Two dimensional electrophoresis separation profiles were compared, and the most characteristic spots were characterized by liquid chromatography-tandem mass spectrometry (LC-MS/MS). We propose proteins extracted from intact cells as an additional trait for bifidobacteria characterization, together with molecular techniques, which can be used to analyze bacterial protein polymorphism and to distinguish among species.


Subject(s)
Bacterial Proteins/metabolism , Bifidobacterium/isolation & purification , Bifidobacterium/metabolism , Gene Expression Regulation, Bacterial/physiology , Bacterial Proteins/genetics , Bifidobacterium/cytology , Electrophoresis, Polyacrylamide Gel/methods , Hydrogen-Ion Concentration , Species Specificity
13.
Mikrobiol Z ; 74(5): 32-42, 2012.
Article in English | MEDLINE | ID: mdl-23120984

ABSTRACT

Antagonistic activity of 13 bifidobacterial strains, isolated from humans, has been studied. It was shown that specific antagonistic activity in bifidobacteria is a strain characteristic and does not depend on species of these microorganisms. It was determined that bifidobacteria are able to produce bacteriocin-like substances against both gram-positive and gram-negative bacteria. Strains Bifidobacterium sp. 278 and B. bifidum 174 produced antimicrobial substances of wide spectrum of activity and manifested the highest antagonistic activity as compared to the rest of bifidobacterial strains studied. The maximal activity of bacteriocin production by strains B. bifidum 174 ma Bifidobacterium sp. 278 occurs between 8-16 hours of cultivation that is in the late logarithmic phase of growth. According to obtained characteristics the antimicrobial substances are complex peptides and belong to the 4th class of bacteriocins.


Subject(s)
Bacteriocins/pharmacology , Bifidobacterium/pathogenicity , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Aged , Aged, 80 and over , Antibiosis , Bacteriocins/chemistry , Bifidobacterium/cytology , Bifidobacterium/isolation & purification , Child, Preschool , Culture Media, Conditioned/isolation & purification , Culture Media, Conditioned/pharmacology , Female , Gastrointestinal Tract/microbiology , Gram-Negative Bacteria/growth & development , Gram-Positive Bacteria/growth & development , Humans , Infant , Male , Microbial Sensitivity Tests , Species Specificity , Time Factors
14.
Glycoconj J ; 27(1): 125-32, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19562481

ABSTRACT

Endo-alpha-N-acetylgalactosaminidase catalyzes the release of Galbeta1-3GalNAc from the core 1-type O-glycan (Galbeta1-3GalNAcalpha1-Ser/Thr) of mucin glycoproteins and synthetic p-nitrophenyl (pNP) alpha-linked substrates. Here, we report the enzymatic syntheses of core 1 disaccharide-containing glycopeptides using the transglycosylation activity of endo-alpha-N-acetylgalactosaminidase (EngBF) from Bifidobacterium longum. The enzyme directly transferred Galbeta1-3GalNAc to serine or threonine residues of bioactive peptides such as PAMP-12, bradykinin, peptide-T and MUC1a when Galbeta1-3GalNAcalpha1-pNP was used as a donor substrate. The enzyme was also found to catalyze the reverse-hydrolysis reaction. EngBF synthesized the core 1 disaccharide-containing oligosaccharides when the enzyme was incubated with either glucose or lactose and Galbeta1-3GalNAc prepared from porcine gastric mucin using bifidobacterial cells expressing endo-alpha-N-acetylgalactosaminidase. Synthesized oligosaccharides are promising prebiotics for bifidobacteria.


Subject(s)
Bifidobacterium/enzymology , Gastric Mucins/biosynthesis , Glycopeptides/biosynthesis , Oligosaccharides/biosynthesis , alpha-N-Acetylgalactosaminidase/metabolism , Amino Acid Sequence , Animals , Bifidobacterium/cytology , Galactosamine/metabolism , Glycopeptides/chemistry , Glycosylation , Hydrolysis , Molecular Sequence Data , Serine/metabolism , Sus scrofa , Threonine/metabolism
15.
J Fluoresc ; 20(1): 365-9, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19784763

ABSTRACT

Fluorescence resonance energy transfer (FRET) that consists of quantum dot as donors and organic fluorophore dyes as acceptors has been a very important method to detect biomolecules such as nucleic acids. In this work, we established a new FRET detection system of Bifidobacterium species-specific 16S rDNA using QD-ROX FRET bioprobe, in which 525 nm QD-DNA conjugation consisted of the carboxyl-modified QD and the amino-modified DNA in the presence of EDC. Both ROX-DNA and the conjugation above could hybridize with the target DNA after forming the QD-ROX bioprobe. When the hybridization made the distance between the QD and ROX to meet FRET effect needed, 525 nm QD fluorescence intensity decreased and ROX fluorescence intensity increased. In the control, there was no notable change of fluorescence intensities without target DNA. It is very clear that the change of the QD and ROX fluorescence intensities provide the good base and guaranty for this rapid and simple detection system.


Subject(s)
Bifidobacterium/cytology , DNA, Bacterial/analysis , Fluorescence Resonance Energy Transfer , Molecular Probes/chemistry , Quantum Dots , Ribosomes/chemistry , Base Sequence , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Nucleic Acid Hybridization , Rhodamines/chemistry , Species Specificity
16.
Biosci Biotechnol Biochem ; 74(12): 2374-84, 2010.
Article in English | MEDLINE | ID: mdl-21150123

ABSTRACT

Bifidobacteria have many beneficial effects for human health. The gastrointestinal tract, where natural colonization of bifidobacteria occurs, is an environment poor in nutrition and oxygen. Therefore, bifidobacteria have many unique glycosidases, transporters, and metabolic enzymes for sugar fermentation to utilize diverse carbohydrates that are not absorbed by host humans and animals. They have a unique, effective central fermentative pathway called bifid shunt. Recently, a novel metabolic pathway that utilizes both human milk oligosaccharides and host glycoconjugates was found. The galacto-N-biose/lacto-N-biose I metabolic pathway plays a key role in colonization in the infant gastrointestinal tract. These pathways involve many unique enzymes and proteins. This review focuses on their molecular mechanisms, as revealed by biochemical and crystallographic studies.


Subject(s)
Bifidobacterium/metabolism , Carbohydrate Metabolism , Carbohydrates , Metabolic Networks and Pathways , Animals , Bifidobacterium/cytology , Bifidobacterium/enzymology , Carbohydrate Sequence , Extracellular Space/enzymology , Glycoside Hydrolases/chemistry , Glycoside Hydrolases/metabolism , Humans , Milk, Human/chemistry , Milk, Human/metabolism , Molecular Sequence Data
17.
Food Microbiol ; 27(2): 236-42, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20141941

ABSTRACT

Viability of probiotic bacteria is traditionally assessed by plate counting which has several limitations, including underestimation of cells in aggregates or chains morphology. We describe a quantitative PCR (qPCR)-based method for an accurate enumeration of viable cells of Bifidobacterium longum NCC2705 exhibiting different morphologies by measuring the mRNA levels of cysB and purB, two constitutively expressed housekeeping genes. Three primer-sets targeting short fragments of 57-bp of cysS and purB and one 400-bp fragment of purB were used. Cell quantification of serially diluted samples showed a good correlation coefficient of R(2) 0.984 +/- 0.003 between plate counts and qRT-PCR for all tested primer sets. Loss of viable cells exposed to a lethal heat stress (56 degrees C, 10, 20 and 30 min) was estimated by qRT-PCR and plate counts. No significant difference was observed using qRT-PCR targeting the 400-bp fragment of purB compared to plate counts indicating that this fragment is a suitable marker of cell viability. In contrast, the use of the 57-bp fragments led to a significant overestimation of viable cell counts (18 +/- 3 and 7 +/- 2 fold for cysB and purB, respectively). Decay of the mRNA fragments was studied by treatment of growing cells with rifampicin prior qRT-PCR. The 400-bp fragment of purB was faster degraded than the 57-bp fragments of cysB and purB. The 400-bp fragment of purB was further used to enumerate viable cells in aggregate state. Cell counts were more than 2 log(10) higher using the qRT-PCR method compared to plate counts. Growing interest in probiotic characteristics of aggregating bacteria cells make this technique a valuable tool to accurately quantify viable probiotic bacteria exhibiting heterogeneous morphology.


Subject(s)
Bifidobacterium/growth & development , Reverse Transcriptase Polymerase Chain Reaction/methods , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Bifidobacterium/cytology , Bifidobacterium/genetics , Colony Count, Microbial/methods , Genes, Bacterial/genetics , RNA, Messenger/metabolism , Stress, Physiological
18.
J Microencapsul ; 27(1): 67-77, 2010.
Article in English | MEDLINE | ID: mdl-19545220

ABSTRACT

The effect of lecithin and starch on viability of alginate encapsulated probiotics was determined at different temperatures. Probiotic organisms (1% v/v>10Log CFU ml(-1)) were encapsulated using alginate (2% w/v), gelatinized starches (2% w/v) and lecithin (0-4% w/v) and stored in sealed containers at 4, 23 and 37 degrees C (to simulate shelf storage conditions). Incorporation of lecithin improved the entrapment efficiency (p < 0.05) and the viability of encapsulated bacteria (p = 0.02). Encapsulated Lactobacillus, Bifidobacterium species and Lactococcus lactis in lecithin containing freeze-dried beads had good survival stability (above 6Log CFU ml(-1)) at 23 degrees C for 12 weeks. The bacteria in the beads showed 6Log survival by the end of 2 weeks at 37 degrees C. Encapsulated L. casei in the alginate beads containing lecithin were also more stable in the yoghurt than the beads without lecithin. SEM analysis of the beads showed an irregular surface for the beads without lecithin.


Subject(s)
Alginates , Bifidobacterium/cytology , Lactobacillus/cytology , Lecithins/metabolism , Starch/metabolism , Alginates/chemistry , Freeze Drying , Glucuronic Acid/chemistry , Hexuronic Acids/chemistry , Microbial Viability
19.
J Microencapsul ; 27(1): 1-9, 2010.
Article in English | MEDLINE | ID: mdl-19845481

ABSTRACT

Silk fibroin was evaluated as a new matrix for immobilized cell fermentation. Silk fibroin was extracted from Bombyx mori cocoon, purified, concentrated in polyethylene glycol solution and diluted to 3 wt% with distilled water. This fibroin solution was used to encapsulate sensitive cells of the probiotic strain, Bifidobacterium longum ATCC 15707. Polymer droplets produced with an encapsulator were collected in liquid nitrogen and lyophilized. A low overall survival of 0.2% was measured after lyophilization. Lyophilized beads were hardened for 24 h under vacuum with an atmosphere of 89% relative humidity. The inoculated beads were colonized in two successive batch fermentations. Structure of silk fibroin beads and colonization of cells were examined with scanning electron microscopy. Colonized beads were tested in continuous fermentations for cell production. A biomass productivity of 1.7 x 10(9) CFU ml(-1) h(-1) was achieved, which was limited by loss of bead structure. This instability might be due to bead degradation by proteolytic activity of cells and/or limited mechanical stability during continuous fermentation in the stirred tank reactor.


Subject(s)
Bifidobacterium/cytology , Bombyx/chemistry , Fermentation , Fibroins/chemistry , Animals , Bifidobacterium/metabolism , Cells, Immobilized/cytology , Cells, Immobilized/metabolism , Fibroins/isolation & purification , Silk/chemistry , Silk/isolation & purification
20.
J Microencapsul ; 27(5): 387-99, 2010.
Article in English | MEDLINE | ID: mdl-19860547

ABSTRACT

To improve survival during exposure to adverse conditions, probiotic Bifidobacterium adolescentis 15703T cells were encapsulated in novel mono-core and multi-core phase-separated gelatine-maltodextrin (GMD) microspheres where the gelatine (G) phase was cross-linked with genipin (GP). Microscopy showed that encapsulated cells were exclusively associated with maltodextrin (MD) core(s). Small (average diameter 37 microm) and large (70 microm) GMD and G microspheres were produced by modulating factors (e.g. mixing speed, surfactant, GP and G concentrations) affecting the size, structural stability and phase-separation. In vitro sequential gastro-intestinal (GI) juice challenge experiments revealed increased survival of cells encapsulated in GMD ( approximately 10(6-7) cfu mL(-1)) and G (approximately 10(5) cfu mL(-1)) microspheres as compared to free cells (approximately 10(4) cfu mL(-1)). In GMD microspheres, the bacteria derive energy from MD to survive during exposure to acid and bile salts. In conclusion, the novel food grade GMD microencapsulation formulation was shown to protect probiotic bifidobacteria from adverse conditions.


Subject(s)
Bifidobacterium/cytology , Drug Compounding/methods , Gelatin/chemistry , Iridoid Glycosides/chemistry , Polysaccharides/chemistry , Probiotics , Cells, Immobilized/cytology , Cross-Linking Reagents/chemistry , Gastric Juice/metabolism , Gastric Juice/microbiology , Gastrointestinal Tract/metabolism , Gastrointestinal Tract/microbiology , Iridoids , Phase Transition
SELECTION OF CITATIONS
SEARCH DETAIL